This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimizu, M. Articles by Weinstein, I. B. Search for Related Content PubMed PubMed Citation Articles by Shimizu, M. Articles by Weinstein, I. B.

(–)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells

Authors' Affiliations: ¹ Herbert Irving Comprehensive Cancer Center and Department of Medicine, Columbia University Medical Center, New York, New York; ² Department of Medicine, Gifu University School of Medicine, Gifu, Japan; and ³ Division Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: I. Bernard Weinstein, Herbert Irving Comprehensive Cancer Center and Department of Medicine, Columbia University Medical Center, HHSC-1509, 701 West 168 Street, New York, NY 10032-2704. Phone: 212-305-6921; Fax: 212-305-6889; E-mail: ibw1{at}columbia.edu.

Purpose: (–)-Epigallocatechin gallate (EGCG) inhibits activation of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor-2 (HER2) and multiple downstream signaling pathways in cancer cell lines. In this study we compared the cellular and molecular effects of EGCG with a well-standardized decaffeinated green tea catechin mixture Polyphenon E (Poly E) on human colon cancer cell lines.

Experimental Design and Results: Both EGCG and Poly E preferentially inhibited growth of the Caco2, HCT116, HT29, SW480, and SW837 colon cancer cells when compared with the FHC normal human fetal colon cell line. The EGFR and HER2 proteins were overexpressed and constitutively activated in all of the colon cancer cell lines when compared with the FHC cell line. Treatment of HT29 cells with EGCG or Poly E caused an increase of cells in G₁ and induced apoptosis. Both EGCG and Poly E caused a decrease in the phosphorylated forms of EGFR and HER2 proteins, and subsequently caused a decrease in the phosphorylated forms of the extracellular signal-regulated kinase and Akt proteins. Similar effects of these compounds were seen when the cells were stimulated with transforming growth factor . Reporter assays indicated that both EGCG and Poly E inhibited the transcriptional activity of the activator protein 1 (AP-1), c-fos, nuclear factor B, and cyclin D1 promoters. The combination of only 1 µg/mL of epicatechin plus 10 µg/mL of EGCG displayed synergistic effects on growth inhibition and induction of apoptosis. Furthermore, when treatment was prolonged for 96 hours, 1 µg/mL of EGCG or Poly E was sufficient to inhibit growth, reduce activation of EGFR and HER2, and induce apoptosis.

Conclusion: Our findings suggest that EGCG or Poly E may be useful in the chemoprevention and/or treatment of colon cancer. Poly E contains about 60% EGCG, yet pure EGCG and Poly E had similar potencies (expressed as µg/ml). Poly E may be preferable because it is easier to prepare and this mixture of catechins may exert synergistic effects.

Key Words: Colon Cancer Cells • EGCG • Polyphenon E • EGFR/HER2 • Mitogen-activated protein kinase

This article has been cited by other articles:

				M. Shimizu, Y. Fukutomi, M. Ninomiya, K. Nagura, T. Kato, H. Araki, M. Suganuma, H. Fujiki, and H. Moriwaki Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3020 - 3025. [Abstract] [Full Text] [PDF]

				S. Adachi, T. Nagao, S. To, A. K. Joe, M. Shimizu, R. Matsushima-Nishiwaki, O. Kozawa, H. Moriwaki, F. R. Maxfield, and I.B. Weinstein (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells Carcinogenesis, October 1, 2008; 29(10): 1986 - 1993. [Abstract] [Full Text] [PDF]

				M. Shimizu, Y. Shirakami, H. Sakai, S. Adachi, K. Hata, Y. Hirose, H. Tsurumi, T. Tanaka, and H. Moriwaki (-)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-db/db Mice Cancer Prevention Research, September 1, 2008; 1(4): 298 - 304. [Abstract] [Full Text] [PDF]

				J. Qin, H.-G. Chen, Q. Yan, M. Deng, J. Liu, S. Doerge, W. Ma, Z. Dong, and D. Wan-Cheng Li Protein Phosphatase-2A Is a Target of Epigallocatechin-3-Gallate and Modulates p53-Bak Apoptotic Pathway Cancer Res., June 1, 2008; 68(11): 4150 - 4162. [Abstract] [Full Text] [PDF]

				J.-S. Choi, Y.-J. Choi, S.-Y. Shin, J. Li, S.-W. Kang, J.-Y. Bae, D. S. Kim, G.-E. Ji, J.-S. Kang, and Y.-H. Kang Dietary Flavonoids Differentially Reduce Oxidized LDL-Induced Apoptosis in Human Endothelial Cells: Role of MAPK- and JAK/STAT-Signaling J. Nutr., June 1, 2008; 138(6): 983 - 990. [Abstract] [Full Text] [PDF]

				C. E. Isaacs, G. Y. Wen, W. Xu, J. H. Jia, L. Rohan, C. Corbo, V. Di Maggio, E. C. Jenkins Jr., and S. Hillier Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus Antimicrob. Agents Chemother., March 1, 2008; 52(3): 962 - 970. [Abstract] [Full Text] [PDF]

				S. Brierley-Hobson Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancer Bioscience Horizons, March 1, 2008; 1(1): 9 - 18. [Abstract] [Full Text] [PDF]

				S. Adachi, T. Nagao, H. I. Ingolfsson, F. R. Maxfield, O. S. Andersen, L. Kopelovich, and I. B. Weinstein The Inhibitory Effect of (-)-Epigallocatechin Gallate on Activation of the Epidermal Growth Factor Receptor Is Associated with Altered Lipid Order in HT29 Colon Cancer Cells Cancer Res., July 1, 2007; 67(13): 6493 - 6501. [Abstract] [Full Text] [PDF]

				R. A. Lubet, C. S. Yang, M.-J. Lee, Y. Hara, I. M. Kapetanovic, J. A. Crowell, V. E. Steele, M. M. Juliana, and C. J. Grubbs Preventive effects of Polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols Mol. Cancer Ther., July 1, 2007; 6(7): 2022 - 2028. [Abstract] [Full Text] [PDF]

				F. Spinella, L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali, and A. Bagnato Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol. Cancer Ther., June 1, 2006; 5(6): 1483 - 1492. [Abstract] [Full Text] [PDF]

				Q. Zhang, X. Tang, Q. Lu, Z. Zhang, J. Rao, and A. D. Le Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1{alpha} protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells Mol. Cancer Ther., May 1, 2006; 5(5): 1227 - 1238. [Abstract] [Full Text] [PDF]

				N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res., March 1, 2006; 66(5): 2500 - 2505. [Abstract] [Full Text] [PDF]

				Z. Hou, S. Sang, H. You, M.-J. Lee, J. Hong, K.-V. Chin, and C. S. Yang Mechanism of Action of (-)-Epigallocatechin-3-Gallate: Auto-oxidation-Dependent Inactivation of Epidermal Growth Factor Receptor and Direct Effects on Growth Inhibition in Human Esophageal Cancer KYSE 150 Cells Cancer Res., September 1, 2005; 65(17): 8049 - 8056. [Abstract] [Full Text] [PDF]